RNU6-202P

Across TCGA pan-cancer cohorts, RNU6-202P RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated RNU6-202P data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RNU6-202P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-202P expression acts as an unfavorable survival marker, although some lineages such as OV and LAML show a favorable association.

KIRC, TGCT, and SKCM are the cancer types where RNU6-202P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Tertile	IV	0.211	0.628	.010	54	view →
TGCT	OS	Tertile	II,III,IV	0.670	1.000	.005	54	view →
SKCM	DFS	Tertile	All	0.016	0.758	<.001	45	view →
MESO	DFS	Tertile	III,IV	0.060	0.423	<.001	45	view →
BRCA	OS	Tertile	II,III,IV	0.813	0.918	.002	39	view →
OV	DFS	Tertile	All	0.518	0.371	.045	36	view →
COAD	OS	Tertile	IV	0.188	0.670	.007	33	view →
LAML	DFS	Tertile	All	0.588	0.350	.002	30	view →
BLCA	DFS	Tertile	IV	0.386	0.479	.001	27	view →
LUSC	OS	Tertile	III,IV	0.054	0.768	<.001	27	view →
ESCA	OS	Quartile	All	0.293	0.504	.010	10	view →
LIHC	DFS	Tertile	II,III,IV	0.038	0.414	<.001	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

RNU6-202P–KIRC (DFS)

Open the KIRC breakdown →